Inhibin
| Category | Compounds |
|---|---|
| Also known as | Inhibin A, Inhibin B, INH |
| Last updated | 2026-04-14 |
| Reading time | 7 min read |
| Tags | TGF-betaFSHreproductiveHPG-axisgonadalfeedback |
Overview
Inhibin is a dimeric glycoprotein hormone belonging to the TGF-beta superfamily that selectively suppresses follicle-stimulating hormone (FSH) secretion from the anterior pituitary. The concept of a gonadal factor that feeds back to inhibit pituitary function was proposed as early as the 1930s, but it was not until 1985 that inhibin was purified from bovine and porcine ovarian follicular fluid by multiple research groups simultaneously.
Two forms of inhibin exist: inhibin A (alpha/beta-A dimer) and inhibin B (alpha/beta-B dimer). Both share a common alpha subunit but differ in their beta subunit. These same beta subunits, when they pair with each other instead of with the alpha subunit, form activin — which has the opposing effect of stimulating FSH. This elegant subunit-sharing arrangement means that the balance between inhibin and activin production is determined by the relative availability of alpha and beta subunits.
Inhibin serves as a key negative feedback signal in the hypothalamic-pituitary-gonadal (HPG) axis. In females, inhibin B is produced by growing follicles and rises during the follicular phase, while inhibin A is produced predominantly by the corpus luteum and peaks in the luteal phase. In males, inhibin B is produced by Sertoli cells and reflects spermatogenic function. Clinically, inhibin measurements are used as markers of ovarian reserve, gonadal function, and certain cancers.
Structure
Inhibin is a heterodimer composed of an alpha subunit linked to one of two beta subunits:
- Inhibin A: alpha/beta-A heterodimer (~32 kDa)
- Inhibin B: alpha/beta-B heterodimer (~32 kDa)
- Alpha subunit gene: INHA (chromosome 2q35)
- Beta subunit genes: INHBA (beta-A), INHBB (beta-B) — shared with activin
Structural features:
- Cystine knot motif — characteristic TGF-beta superfamily fold in both subunits
- Interchain disulfide bond — links alpha to beta subunit
- N-linked glycosylation — alpha subunit is heavily glycosylated; glycosylation affects half-life and bioactivity
- The alpha subunit is unique to inhibin (not found in activin or other TGF-beta members), making it the defining structural feature that distinguishes inhibin from activin
Mechanism of Action
FSH Suppression
Inhibin's primary biological action is suppressing FSH at the pituitary level:
- Inhibin acts directly on anterior pituitary gonadotroph cells
- The mechanism involves competitive antagonism at the activin receptor: inhibin binds to ActRIIA/ActRIIB via its beta subunit, but the alpha subunit engages the co-receptor betaglycan (TGF-beta type III receptor), forming a complex that blocks activin-mediated Smad2/3 signaling
- This effectively prevents activin from stimulating FSHbeta gene transcription
- Inhibin does not suppress LH (luteinizing hormone) to the same degree, providing selective FSH regulation
- This selective FSH suppression without LH effects distinguishes inhibin from sex steroid feedback, which affects both gonadotropins
HPG Axis Integration
Inhibin operates within the larger HPG feedback system:
- GnRH (hypothalamic) drives both LH and FSH release
- Activin (pituitary/local) enhances FSH selectively
- Inhibin (gonadal) suppresses FSH selectively
- Follistatin (pituitary/local) neutralizes activin
- Kisspeptin (hypothalamic) modulates GnRH pulsatility
This multi-layered regulatory system allows differential control of FSH and LH despite both being regulated by the same GnRH signal.
Female Reproductive Cycle
During the menstrual cycle, inhibin isoforms show distinct patterns:
- Inhibin B — rises in the early-to-mid follicular phase, produced by growing follicles; suppresses FSH to prevent excessive follicle recruitment
- Inhibin A — peaks in the luteal phase, produced by the corpus luteum and dominant follicle; maintains FSH suppression after ovulation
- Declining inhibin B in the late luteal/early follicular transition allows FSH to rise, initiating the next wave of follicular recruitment
Male Reproductive Function
In males, inhibin B is the predominant form:
- Produced by Sertoli cells in response to FSH stimulation
- Circulating inhibin B levels reflect Sertoli cell function and, indirectly, spermatogenic activity
- Low inhibin B with elevated FSH indicates primary spermatogenic failure
- Forms a negative feedback loop: FSH stimulates Sertoli cells to produce inhibin B, which suppresses further FSH release
Research Summary
| Area of Study | Key Finding | Notable Reference |
|---|---|---|
| Purification | Inhibin purified from ovarian follicular fluid; alpha/beta dimeric structure identified | Robertson et al., Molecular & Cellular Endocrinology, 1985 |
| FSH selectivity | Inhibin selectively suppresses FSH without comparable LH suppression | Ying, Endocrine Reviews, 1988 |
| Betaglycan mechanism | Inhibin binds ActRII via beta subunit and betaglycan via alpha subunit, blocking activin signaling | Lewis et al., Nature, 2000 |
| Ovarian reserve | Inhibin B as a marker of ovarian reserve; declines with age and diminished ovarian reserve | Seifer et al., Fertility and Sterility, 1999 |
| Male infertility | Low inhibin B with elevated FSH indicates primary testicular failure | Pierik et al., Journal of Clinical Endocrinology & Metabolism, 1998 |
| Tumor marker | Inhibin A/B elevated in granulosa cell tumors of the ovary | Lappohn et al., New England Journal of Medicine, 1989 |
| Prenatal screening | Inhibin A is a component of the quad screen for Down syndrome detection | Wald et al., Prenatal Diagnosis, 1996 |
| Tumor suppressor | Alpha subunit knockout mice develop gonadal tumors, suggesting INHA acts as a tumor suppressor gene | Matzuk et al., Nature, 1992 |
Pharmacokinetics
- Half-life: Approximately 30-60 minutes for inhibin A (longer with glycosylation); inhibin B has comparable kinetics
- Circulating levels (female): Inhibin A: <5-60 pg/mL (varies with cycle phase); Inhibin B: 10-200 pg/mL (highest in early follicular phase)
- Circulating levels (male): Inhibin B: 80-350 pg/mL (relatively stable; reflects Sertoli cell function)
- Clearance: Hepatic and renal
- Binding: Circulates free and bound to various proteins
Clinical Applications
Diagnostic Uses
| Application | Measurement | Interpretation |
|---|---|---|
| Ovarian reserve | Inhibin B (day 3) | Low levels suggest diminished ovarian reserve |
| Granulosa cell tumor | Inhibin A and B | Elevated levels serve as tumor biomarker |
| Down syndrome screening | Inhibin A (maternal serum) | Elevated in affected pregnancies |
| Male infertility | Inhibin B | Low levels with high FSH indicate primary testicular failure |
| Menopause | Inhibin B decline | Falls years before menopause; early marker of reproductive aging |
Common Discussion Topics
-
Inhibin vs. activin — the yin and yang — Inhibin and activin provide opposing signals from shared subunits. This elegant molecular switch allows precise FSH regulation without requiring separate gene families.
-
Ovarian reserve testing — Inhibin B, alongside AMH (anti-Mullerian hormone) and day-3 FSH, is used in fertility evaluation. Declining inhibin B is among the earliest indicators of diminishing ovarian reserve.
-
Inhibin as a tumor suppressor — The finding that INHA knockout mice develop gonadal stromal tumors was unexpected and established inhibin as a functional tumor suppressor in the gonads.
-
Connection to myostatin signaling — Because inhibin interacts with ActRIIB, it can modulate myostatin signaling. This creates cross-talk between reproductive and musculoskeletal regulatory systems.
-
Contraceptive potential — Recombinant inhibin has been explored as a potential male contraceptive approach (selective FSH suppression without testosterone suppression), though delivery challenges have limited development.
Related Compounds
- Activin — opposing TGF-beta member composed of inhibin beta subunits; stimulates FSH
- Follistatin — activin-binding protein that indirectly modulates the activin-inhibin balance
- GnRH — hypothalamic hormone that drives gonadotropin release upstream of inhibin feedback
- Kisspeptin — neuropeptide regulating GnRH pulsatility and puberty onset
- Myostatin — TGF-beta member sharing ActRIIB receptor interactions with inhibin
Sourcing research-grade compounds
Obtaining high-purity, research-grade Inhibin requires verified and trusted suppliers with third-party COA testing and transparent sourcing practices.
White Market Peptides — Verified Supplier →Join the discussion
See how the community is discussing Inhibin. Share your experience, ask questions, and explore protocols on PepAtlas.
Related entries
- Activin— A dimeric TGF-beta superfamily member composed of inhibin beta subunits that stimulates FSH secretion, regulates reproductive function, influences muscle mass, and plays diverse roles in development, inflammation, and tissue repair.
- Follistatin— A naturally occurring glycoprotein that binds and neutralizes members of the TGF-beta superfamily — most notably myostatin and activin — studied extensively for its role in muscle growth regulation, reproductive biology, and as a potential therapeutic target for muscle-wasting conditions.
- GnRH (Gonadotropin-Releasing Hormone)— A hypothalamic decapeptide that serves as the master regulator of the hypothalamic-pituitary-gonadal axis, controlling reproduction through pulsatile release patterns, with numerous synthetic analogs used clinically for fertility, cancer, and endocrine disorders.
- Kisspeptin— A hypothalamic neuropeptide product of the KISS1 gene that functions as the primary upstream regulator of GnRH neuron activity, playing a central role in puberty onset, reproductive function, and fertility — now under clinical investigation as a novel fertility treatment.
- Myostatin— A TGF-beta superfamily member that functions as the body's primary negative regulator of skeletal muscle mass — naturally occurring loss-of-function mutations produce dramatic muscular hypertrophy in cattle, dogs, and humans.